| 000 | 01719 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514002835.0 | ||
| 264 | 0 | _c20010712 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(00)05066-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNicholson, K G | |
| 245 | 0 | 0 |
_aSafety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 2001 |
||
| 300 |
_a1937-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 |
_aDucks _xvirology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 | _aInfluenza A Virus, H5N1 Subtype |
| 650 | 0 | 4 |
_aInfluenza A virus _ximmunology |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza in Birds _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolysorbates _xadministration & dosage |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 |
_aSqualene _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccines, Inactivated _xadministration & dosage |
| 700 | 1 | _aColegate, A E | |
| 700 | 1 | _aPodda, A | |
| 700 | 1 | _aStephenson, I | |
| 700 | 1 | _aWood, J | |
| 700 | 1 | _aYpma, E | |
| 700 | 1 | _aZambon, M C | |
| 773 | 0 |
_tLancet (London, England) _gvol. 357 _gno. 9272 _gp. 1937-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(00)05066-2 _zAvailable from publisher's website |
| 999 |
_c11354964 _d11354964 |
||